Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation 2022-01-17 21:50
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease 2022-01-17 14:29
Jacobio Receives IND Approval for Aurora A Inhibitor JAB-2485 from FDA 2022-01-17 09:04
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin 2022-01-15 03:30
I-Mab Announces Execution of Senior Management Team Share Purchase Plan 2022-01-14 21:00
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference 2022-01-13 08:52
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors 2022-01-12 21:00
Gracell Biotechnologies Unveils Innovation Center in U.S. 2022-01-12 21:00
Bionomics Limited participated in the H.C Wainwright BioConnect Conference 2022-01-12 19:00
Qilian International Holding Group Limited Releases 2022 Chairman Letter 2022-01-11 20:00
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct 2022-01-11 05:30
CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA 2022-01-10 21:50
KAZIA THERAPEUTICS TO PRESENT AT HC WAINWRIGHT BIOCONNECT CONFERENCE 2022-01-07 21:00
InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development 2022-01-07 08:30
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases 2022-01-06 22:00
I-Mab Announces Senior Management Team Share Purchase Plan 2022-01-06 21:00
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER 2022-01-06 19:00
Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines 2022-01-06 14:45
Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference 2022-01-06 08:30
1 87 88 89 90 91 165